,reactionmeddraversionpt,reactionmeddrapt,safetyreportid,reactionoutcome
0,22.0,Fatigue,16117029,
1,22.0,Full blood count decreased,16117029,
0,22.0,White blood cell count decreased,16117035,3
1,22.0,Asthma,16117035,3
2,22.0,Red blood cell count decreased,16117035,3
3,22.0,Cough,16117035,3
0,22.0,Dry mouth,16117067,
1,22.0,Fatigue,16117067,
0,21.1,Dizziness,16117077,3
1,21.1,Malaise,16117077,3
2,21.1,Dysarthria,16117077,3
0,22.0,Anxiety,16117079,
1,22.0,Dyspnoea,16117079,
2,22.0,Flushing,16117079,
3,22.0,Abdominal discomfort,16117079,
4,22.0,Paraesthesia,16117079,
5,22.0,Hypoaesthesia,16117079,
0,21.1,Cholangitis,16117108,1
1,21.1,Cholelithiasis,16117108,1
0,21.1,Nephropathy toxic,16117168,1
0,22.0,Diarrhoea,16117182,
0,21.1,Cardiac fibrillation,16117183,6
0,22.0,Gastrointestinal toxicity,16117204,1
1,22.0,Fatigue,16117204,6
2,22.0,Therapeutic product effect incomplete,16117204,6
3,22.0,Product use in unapproved indication,16117204,6
4,22.0,Anaemia,16117204,6
5,22.0,Sensory disturbance,16117204,6
6,22.0,Restless legs syndrome,16117204,1
7,22.0,Drug intolerance,16117204,6
8,22.0,Cancer pain,16117204,1
9,22.0,Sleep deficit,16117204,6
0,21.1,Death,16117205,5
0,22.0,Death,16117270,5
0,22.0,Lung neoplasm malignant,16117285,5
1,22.0,Malignant neoplasm of eye,16117285,5
0,22.0,Hypotension,16117303,1
0,21.1,Haemorrhagic transformation stroke,16117350,2
1,21.1,Drug interaction,16117350,2
0,22.1,Neck pain,16117354,1
1,22.1,Musculoskeletal pain,16117354,1
2,22.1,Sinusitis,16117354,1
3,22.1,Pain in extremity,16117354,3
4,22.1,Pneumonia,16117354,5
5,22.1,Skin infection,16117354,3
6,22.1,Hypoaesthesia,16117354,3
0,21.1,Erythema,16117403,3
1,21.1,Nausea,16117403,3
2,21.1,Hypertension,16117403,3
3,21.1,Hot flush,16117403,3
4,21.1,Headache,16117403,3
5,21.1,Tachycardia,16117403,3
6,21.1,Tremor,16117403,3
0,22.1,Autoimmune pancreatitis,16117447,1
1,22.1,Immune-mediated enterocolitis,16117447,1
2,22.1,Diabetic ketoacidotic hyperglycaemic coma,16117447,1
0,21.1,Raynaud^s phenomenon,16117454,3
1,21.1,Interstitial lung disease,16117454,3
0,21.1,Ulcer,16117528,6
1,21.1,Stomatitis,16117528,6
2,21.1,Nasal inflammation,16117528,6
3,21.1,Laryngeal inflammation,16117528,6
0,21.1,Neutropenia,16117592,1
1,21.1,Cystitis,16117592,1
0,22.0,Malaise,16117599,1
1,22.0,Hyperthermia,16117599,1
2,22.0,Tachycardia,16117599,1
3,22.0,Loss of consciousness,16117599,1
0,21.1,Acute generalised exanthematous pustulosis,16117617,1
1,21.1,Incorrect drug administration rate,16117617,1
0,21.1,Incorrect drug administration rate,16117618,1
1,21.1,Acute generalised exanthematous pustulosis,16117618,1
2,21.1,Pruritus,16117618,1
3,21.1,Dermatitis allergic,16117618,1
0,21.1,Back pain,16117628,6
1,21.1,Chills,16117628,1
2,21.1,Headache,16117628,1
3,21.1,Hypertension,16117628,1
0,22.0,Carcinoembryonic antigen increased,16117653,1
0,21.1,Drug interaction,16117660,6
1,21.1,Ototoxicity,16117660,6
0,21.1,Death,16117700,5
0,21.1,Death,16117702,5
0,21.1,Drug ineffective,16117719,6
1,21.1,Proctalgia,16117719,3
2,21.1,Micturition urgency,16117719,3
3,21.1,Cystitis noninfective,16117719,3
4,21.1,Bladder pain,16117719,3
5,21.1,Dysuria,16117719,3
0,22.0,Metastases to central nervous system,16117730,6
1,22.0,Gait disturbance,16117730,6
2,22.0,Speech disorder,16117730,6
3,22.0,Malignant neoplasm progression,16117730,6
4,22.0,Asthenia,16117730,6
5,22.0,Erythema,16117730,1
0,22.0,Throat irritation,16117733,1
1,22.0,Fatigue,16117733,6
2,22.0,Arthritis,16117733,3
3,22.0,Pyelocaliectasis,16117733,6
4,22.0,Hyponatraemia,16117733,3
5,22.0,Bone disorder,16117733,6
6,22.0,Blood sodium decreased,16117733,1
7,22.0,Blood pressure increased,16117733,6
8,22.0,Oropharyngeal pain,16117733,2
9,22.0,Weight decreased,16117733,6
10,22.0,Bronchial secretion retention,16117733,6
11,22.0,Ovarian cancer recurrent,16117733,6
12,22.0,Headache,16117733,1
13,22.0,Pain,16117733,1
14,22.0,Arteriosclerosis,16117733,6
15,22.0,Myalgia,16117733,1
16,22.0,Chills,16117733,1
17,22.0,Pain in jaw,16117733,6
18,22.0,Protein urine present,16117733,6
19,22.0,Pyrexia,16117733,1
20,22.0,Dysuria,16117733,6
21,22.0,Epigastric discomfort,16117733,1
22,22.0,Musculoskeletal pain,16117733,1
23,22.0,Arthralgia,16117733,6
24,22.0,Pulmonary fibrosis,16117733,6
25,22.0,Ear pain,16117733,3
26,22.0,Hypertension,16117733,6
27,22.0,Protein total increased,16117733,6
0,21.1,Osteonecrosis,16117757,6
0,21.1,Bradycardia,16117761,1
0,21.1,Cardiac disorder,16117792,6
0,21.1,Cytokine release syndrome,16117821,6
1,21.1,Fall,16117821,6
2,21.1,Pharyngeal oedema,16117821,3
3,21.1,Pneumonia,16117821,1
4,21.1,Overdose,16117821,6
5,21.1,Dysphagia,16117821,3
6,21.1,Insomnia,16117821,3
7,21.1,Night sweats,16117821,3
8,21.1,Pneumonitis,16117821,1
0,21.1,Tremor,16117840,1
0,22.0,Gastrointestinal haemorrhage,16117891,1
0,21.1,Adenocarcinoma pancreas,16117914,6
0,21.1,General physical health deterioration,16117929,1
1,21.1,Fatigue,16117929,6
2,21.1,Dehydration,16117929,1
3,21.1,Neutrophil count decreased,16117929,1
4,21.1,Leukopenia,16117929,1
5,21.1,Diarrhoea,16117929,1
6,21.1,Decreased appetite,16117929,1
7,21.1,Neutrophil count decreased,16117929,1
8,21.1,White blood cell count decreased,16117929,1
0,22.0,Gait inability,16117935,4
1,22.0,Polyneuropathy,16117935,2
0,21.1,Injection site paraesthesia,16117941,1
1,21.1,Infusion site erythema,16117941,1
2,21.1,Infusion site warmth,16117941,1
3,21.1,Administration site extravasation,16117941,1
0,22.1,Urinary tract infection,16117956,6
1,22.1,Hepatic failure,16117956,5
2,22.1,Metastasis,16117956,5
3,22.1,Malignant neoplasm progression,16117956,6
0,21.1,Malignant neoplasm progression,16117960,6
1,21.1,Metastases to bone,16117960,6
0,21.1,Arthralgia,16117962,6
1,21.1,Gastrooesophageal reflux disease,16117962,3
2,21.1,White blood cell count decreased,16117962,6
0,22.0,Malignant neoplasm progression,16117965,1
1,22.0,Vocal cord paralysis,16117965,6
2,22.0,Pneumonia,16117965,6
3,22.0,Liver disorder,16117965,1
4,22.0,Pulmonary toxicity,16117965,1
0,22.0,Abscess,16118018,2
1,22.0,Bronchial obstruction,16118018,3
0,21.1,Malignant neoplasm progression,16118037,6
1,21.1,Interstitial lung disease,16118037,3
0,21.1,Conduction disorder,16118117,6
1,21.1,Sinus bradycardia,16118117,6
2,21.1,Electrocardiogram low voltage,16118117,6
3,21.1,Blood pressure systolic increased,16118117,6
0,21.1,Neuropathy peripheral,16118124,3
1,21.1,Paraesthesia,16118124,3
2,21.1,Hypoaesthesia,16118124,3
0,22.0,Product use in unapproved indication,16118168,6
1,22.0,Death,16118168,5
0,22.0,Infectious pleural effusion,16118188,3
1,22.0,Hepatic cirrhosis,16118188,6
0,21.1,Death,16118247,5
0,21.1,Death,16118249,5
0,22.0,Weight decreased,16118269,2
1,22.0,Stomatitis,16118269,2
2,22.0,Periorbital oedema,16118269,2
3,22.0,Hypertension,16118269,2
4,22.0,Diarrhoea,16118269,2
5,22.0,Genital lesion,16118269,6
6,22.0,Dysgeusia,16118269,2
7,22.0,Face oedema,16118269,6
8,22.0,Yellow skin,16118269,2
9,22.0,Decreased appetite,16118269,2
10,22.0,Thrombocytopenia,16118269,2
0,22.1,Hepatic cancer,16118305,6
1,22.1,Disease progression,16118305,6
2,22.1,Colon neoplasm,16118305,6
3,22.1,Drug ineffective,16118305,6
0,21.1,Oesophageal stenosis,16118306,3
0,21.1,Death,16118315,5
0,21.1,Liver disorder,16118367,6
1,21.1,Recurrent cancer,16118367,6
0,22.0,Fall,16118382,6
1,22.0,Adrenal insufficiency,16118382,4
0,22.0,Psychological trauma,16118396,6
1,22.0,Alopecia,16118396,2
0,21.1,Pain,16118405,6
1,21.1,Anxiety,16118405,6
2,21.1,Psychological trauma,16118405,6
3,21.1,Emotional distress,16118405,6
4,21.1,Impaired quality of life,16118405,6
5,21.1,Alopecia,16118405,2
0,22.0,Pain,16118423,6
1,22.0,Impaired quality of life,16118423,6
2,22.0,Psychological trauma,16118423,6
3,22.0,Alopecia,16118423,2
4,22.0,Emotional distress,16118423,6
5,22.0,Anxiety,16118423,6
0,22.0,Alopecia,16118428,3
1,22.0,Psychological trauma,16118428,6
0,22.0,Pain,16118429,6
1,22.0,Impaired quality of life,16118429,6
2,22.0,Anxiety,16118429,6
3,22.0,Psychological trauma,16118429,6
4,22.0,Alopecia,16118429,2
5,22.0,Emotional distress,16118429,6
0,22.0,Therapeutic product effect incomplete,16118470,3
1,22.0,Abscess,16118470,2
0,22.0,Breast cancer,16118478,3
1,22.0,Malignant neoplasm progression,16118478,3
0,22.1,Haemorrhagic stroke,16118485,4
0,22.0,Fatigue,16118493,3
1,22.0,Hypertension,16118493,3
2,22.0,Arthralgia,16118493,3
3,22.0,Palmar-plantar erythrodysaesthesia syndrome,16118493,3
4,22.0,Thrombocytopenia,16118493,3
5,22.0,Neutropenia,16118493,3
6,22.0,Back pain,16118493,3
0,21.1,Condition aggravated,16118494,5
1,21.1,Ischaemia,16118494,5
2,21.1,Thrombosis,16118494,5
0,22.0,Non-cirrhotic portal hypertension,16118514,6
0,21.1,Interstitial lung disease,16118556,6
0,22.0,Non-cirrhotic portal hypertension,16118583,6
0,22.0,Death,16118608,5
0,21.1,Breast cancer,16118638,5
1,21.1,Oedema,16118638,6
0,21.1,Blood potassium decreased,16118640,6
0,21.1,Dementia,16118641,6
1,21.1,Hot flush,16118641,6
2,21.1,Night sweats,16118641,6
0,21.1,Hair texture abnormal,16118714,3
1,21.1,Hair disorder,16118714,3
2,21.1,Alopecia,16118714,3
3,21.1,Hair colour changes,16118714,3
4,21.1,Madarosis,16118714,3
5,21.1,Anxiety disorder,16118714,6
0,21.1,Death,16118756,5
0,21.1,Stomatitis,16118758,6
1,21.1,Aphonia,16118758,6
2,21.1,Myocardial infarction,16118758,6
0,21.1,Adverse drug reaction,16118759,6
1,21.1,Pulmonary oedema,16118759,6
0,21.1,Death,16118760,5
1,21.1,Malignant neoplasm progression,16118760,6
0,21.1,Death,16118761,5
0,21.1,Death,16118763,5
0,22.0,Large intestine perforation,16118764,3
1,22.0,Drug ineffective,16118764,6
2,22.0,Diverticulitis,16118764,3
0,21.1,Hepatocellular injury,16118766,1
0,21.1,Death,16118771,5
0,21.1,Death,16118785,5
0,21.1,Pancreatitis acute,16118896,2
1,21.1,Abdominal pain,16118896,1
0,21.1,Diarrhoea,16118926,2
1,21.1,Asthenia,16118926,6
2,21.1,Nausea,16118926,2
3,21.1,Gait inability,16118926,6
0,21.1,Liver function test increased,16118927,1
1,21.1,Decreased appetite,16118927,1
2,21.1,Nausea,16118927,1
3,21.1,Diastolic dysfunction,16118927,1
4,21.1,Anaemia,16118927,1
5,21.1,Constipation,16118927,1
6,21.1,Constipation,16118927,1
7,21.1,Neuropathy peripheral,16118927,1
8,21.1,Diarrhoea,16118927,1
9,21.1,Abdominal pain,16118927,1
10,21.1,Fatigue,16118927,1
0,21.1,Pulmonary oedema,16118935,2
1,21.1,Eye swelling,16118935,6
2,21.1,Skin mass,16118935,2
0,22.1,Neoplasm progression,16118936,6
1,22.1,Laryngitis,16118936,2
2,22.1,Peripheral swelling,16118936,1
0,21.1,Death,16118939,5
0,22.1,Nasopharyngitis,16118942,1
1,22.1,Alopecia,16118942,6
2,22.1,White blood cell count decreased,16118942,3
0,21.1,Dementia,16118959,6
0,21.1,Agranulocytosis,16118960,1
0,22.0,Chest pain,16118967,3
1,22.0,Second primary malignancy,16118967,3
2,22.0,Thyroid cancer,16118967,3
3,22.0,Dementia Alzheimer^s type,16118967,3
0,21.1,Asbestosis,16118978,3
1,21.1,Fall,16118978,2
0,21.1,Death,16118980,5
0,22.0,Pancytopenia,16118995,2
0,21.1,White blood cell count decreased,16119011,1
1,21.1,Agranulocytosis,16119011,1
0,21.1,Agranulocytosis,16119017,1
0,22.0,Dehydration,16119066,3
1,22.0,Arthropathy,16119066,3
2,22.0,Hypotension,16119066,6
3,22.0,Gastric ulcer,16119066,1
4,22.0,Lung infection,16119066,3
5,22.0,Poor quality sleep,16119066,3
6,22.0,Tooth demineralisation,16119066,3
7,22.0,Pharyngeal inflammation,16119066,3
8,22.0,Headache,16119066,3
9,22.0,Decreased appetite,16119066,3
10,22.0,Blood pressure fluctuation,16119066,3
11,22.0,Stomatitis,16119066,3
12,22.0,Abdominal pain upper,16119066,3
13,22.0,Weight decreased,16119066,3
14,22.0,Pain,16119066,3
15,22.0,Pneumonia,16119066,3
16,22.0,Infection,16119066,3
17,22.0,Nausea,16119066,3
18,22.0,Back pain,16119066,3
19,22.0,Nasal inflammation,16119066,3
20,22.0,Diarrhoea,16119066,3
21,22.0,Blood pressure increased,16119066,2
22,22.0,Jaw disorder,16119066,3
0,22.0,Non-small cell lung cancer recurrent,16119091,6
0,21.1,Colitis ischaemic,16119096,2
0,22.0,Acute motor-sensory axonal neuropathy,16119145,3
1,22.0,Superinfection bacterial,16119145,1
2,22.0,Face oedema,16119145,1
3,22.0,Conjunctivitis,16119145,1
4,22.0,Toxicity to various agents,16119145,1
5,22.0,Rash,16119145,3
6,22.0,Depression,16119145,2
7,22.0,Erythema,16119145,3
0,21.1,Malignant neoplasm progression,16119200,3
0,21.1,Neoplasm progression,16119271,6
0,21.1,Shoulder operation,16119298,6
0,22.0,Subarachnoid haemorrhage,16119309,1
1,22.0,Haemorrhage,16119309,6
0,22.0,Constipation,16119337,3
1,22.0,Fatigue,16119337,3
2,22.0,Alopecia,16119337,3
3,22.0,Diarrhoea,16119337,3
0,21.1,Hypertension,16119418,6
1,21.1,Weight decreased,16119418,6
2,21.1,Liver disorder,16119418,6
3,21.1,Monocyte count decreased,16119418,6
4,21.1,Neutrophil count decreased,16119418,6
5,21.1,Asthenia,16119418,6
6,21.1,Vomiting,16119418,6
7,21.1,Neoplasm progression,16119418,6
8,21.1,Lymphocyte count decreased,16119418,6
9,21.1,White blood cell count decreased,16119418,6
0,21.1,Second primary malignancy,16119420,3
1,21.1,Acute myeloid leukaemia,16119420,3
0,21.1,Alopecia,16119426,3
1,21.1,Hair texture abnormal,16119426,3
2,21.1,Hair disorder,16119426,3
3,21.1,Madarosis,16119426,3
4,21.1,Hair colour changes,16119426,3
0,22.0,Alopecia,16119457,6
1,22.0,Madarosis,16119457,6
2,22.0,Hair colour changes,16119457,6
3,22.0,Hair disorder,16119457,6
4,22.0,Hair texture abnormal,16119457,6
0,21.1,Throat tightness,16119466,1
0,21.1,Anaemia,16119521,6
0,21.1,Asthenia,16119540,3
1,21.1,Insomnia,16119540,3
2,21.1,Nausea,16119540,3
3,21.1,Anxiety,16119540,3
0,21.1,Interstitial lung disease,16119568,6
0,22.0,Stomatitis,16119580,3
1,22.0,Decreased appetite,16119580,3
2,22.0,Decreased appetite,16119580,1
3,22.0,Dysgeusia,16119580,3
4,22.0,Hepatocellular injury,16119580,3
5,22.0,Fatigue,16119580,3
6,22.0,Dyspnoea,16119580,3
0,22.0,Constipation,16119598,6
1,22.0,Pain,16119598,6
2,22.0,Product use in unapproved indication,16119598,6
0,21.1,Neuropathy peripheral,16119640,6
0,22.0,Malaise,16119641,6
1,22.0,Epistaxis,16119641,6
2,22.0,Pleural effusion,16119641,6
3,22.0,Hypertension,16119641,2
4,22.0,Pericardial effusion,16119641,6
5,22.0,Fatigue,16119641,6
6,22.0,Pollakiuria,16119641,1
7,22.0,Dyspnoea,16119641,1
8,22.0,Diarrhoea,16119641,3
9,22.0,Nausea,16119641,2
10,22.0,Heart rate irregular,16119641,1
11,22.0,Eructation,16119641,6
0,21.1,Neuropathy peripheral,16119642,6
0,21.1,Breast cancer metastatic,16119662,6
1,21.1,Malignant neoplasm progression,16119662,6
0,21.1,Therapy partial responder,16119678,6
0,22.0,Bradycardia,16119692,1
1,22.0,Asthenia,16119692,1
2,22.0,Nausea,16119692,1
0,22.0,Vomiting,16119717,3
1,22.0,Dizziness,16119717,1
2,22.0,Chest pain,16119717,3
3,22.0,Taste disorder,16119717,3
4,22.0,Lung infection,16119717,3
5,22.0,Constipation,16119717,3
6,22.0,Rash,16119717,3
7,22.0,Diarrhoea,16119717,3
8,22.0,Dyspnoea,16119717,3
9,22.0,Fatigue,16119717,3
10,22.0,Pleural effusion,16119717,3
11,22.0,Platelet count increased,16119717,3
12,22.0,Malignant neoplasm progression,16119717,3
13,22.0,Musculoskeletal chest pain,16119717,3
14,22.0,Protein total decreased,16119717,3
15,22.0,White blood cell disorder,16119717,3
16,22.0,Nausea,16119717,3
17,22.0,Abdominal pain upper,16119717,3
18,22.0,Dehydration,16119717,3
19,22.0,Blood pressure increased,16119717,3
20,22.0,Decreased appetite,16119717,3
21,22.0,Weight decreased,16119717,3
22,22.0,Gastrooesophageal reflux disease,16119717,3
0,22.0,Cough,16119729,3
1,22.0,Immune-mediated adverse reaction,16119729,2
2,22.0,Malignant neoplasm progression,16119729,3
3,22.0,Diarrhoea,16119729,2
0,22.1,Cellulitis,16119731,1
1,22.1,Adrenal insufficiency,16119731,1
0,22.0,Colitis ulcerative,16119755,6
0,21.1,Neuropathy peripheral,16119780,6
0,21.1,Hypertransaminasaemia,16119813,3
0,22.0,Pneumonitis,16119819,2
0,22.0,Oral pain,16119869,3
1,22.0,General physical health deterioration,16119869,3
2,22.0,Candida infection,16119869,6
3,22.0,Epistaxis,16119869,3
4,22.0,Skin exfoliation,16119869,2
5,22.0,Malaise,16119869,1
6,22.0,Vomiting,16119869,1
7,22.0,Dizziness,16119869,3
8,22.0,Fatigue,16119869,3
9,22.0,Hypotension,16119869,3
10,22.0,Asthenia,16119869,2
11,22.0,Vomiting,16119869,1
12,22.0,Rash erythematous,16119869,1
0,22.0,Gastritis,16119874,6
1,22.0,Cystitis,16119874,6
2,22.0,Death,16119874,5
0,21.1,Axillary pain,16119949,6
1,21.1,Pericardial effusion,16119949,6
0,22.0,Lung disorder,16120004,2
0,21.1,Cerebral disorder,16120023,6
0,21.1,Asthma,16120043,6
0,21.1,Metastases to liver,16120072,3
0,22.0,Dizziness,16120107,6
1,22.0,Venous thrombosis limb,16120107,1
2,22.0,Pulmonary infarction,16120107,1
3,22.0,Dyspnoea,16120107,6
4,22.0,Brain natriuretic peptide increased,16120107,6
5,22.0,Pulmonary embolism,16120107,1
6,22.0,Right ventricular failure,16120107,6
0,21.1,Aspergillus infection,16120108,5
1,21.1,Sepsis,16120108,5
2,21.1,Acute myeloid leukaemia,16120108,6
0,21.1,Neurotoxicity,16120116,6
1,21.1,Cardiotoxicity,16120116,6
0,21.1,Off label use,16120121,6
1,21.1,Neutropenia,16120121,6
2,21.1,Cataract,16120121,6
0,21.1,Coronary artery thrombosis,16120151,6
1,21.1,Pulmonary embolism,16120151,6
2,21.1,Deep vein thrombosis,16120151,6
0,21.1,Headache,16120152,1
1,21.1,Product substitution issue,16120152,6
2,21.1,Vision blurred,16120152,3
0,21.1,Myalgia,16120153,3
1,21.1,Arthralgia,16120153,3
0,21.1,Constipation,16120169,3
1,21.1,Gastrooesophageal reflux disease,16120169,2
0,21.1,Dry skin,16120171,3
1,21.1,Erythema,16120171,6
0,21.1,Blood pressure decreased,16120176,1
1,21.1,Hyperhidrosis,16120176,6
2,21.1,Hot flush,16120176,1
0,21.1,Insomnia,16120179,3
1,21.1,Emotional disorder,16120179,3
2,21.1,Abdominal pain upper,16120179,6
3,21.1,Anxiety,16120179,3
0,21.1,Death,16120264,5
1,21.1,Off label use,16120264,6
0,22.0,Acute myocardial infarction,16120265,6
0,21.1,Bradycardia,16120327,1
1,21.1,Sinus node dysfunction,16120327,1
2,21.1,Dizziness,16120327,1
0,21.1,Osteonecrosis of jaw,16120348,3
1,21.1,Mucosal hypertrophy,16120348,6
2,21.1,Gingival erythema,16120348,6
3,21.1,Peri-implantitis,16120348,6
4,21.1,Pain in jaw,16120348,6
5,21.1,Gingival swelling,16120348,6
0,21.1,Anaemia,16120351,2
1,21.1,Abdominal pain upper,16120351,1
2,21.1,Product use in unapproved indication,16120351,6
3,21.1,Renal pain,16120351,1
4,21.1,Skin discolouration,16120351,1
5,21.1,Vision blurred,16120351,1
6,21.1,Epistaxis,16120351,1
7,21.1,Peripheral swelling,16120351,1
8,21.1,Renal atrophy,16120351,1
9,21.1,Movement disorder,16120351,2
10,21.1,Mouth ulceration,16120351,1
0,22.0,Metastases to bone,16120356,1
1,22.0,Osteolysis,16120356,6
2,22.0,Right ventricular dysfunction,16120356,6
3,22.0,Diarrhoea,16120356,6
4,22.0,Metastases to nervous system,16120356,1
5,22.0,Dyspnoea,16120356,6
6,22.0,Oedema peripheral,16120356,6
7,22.0,Decreased appetite,16120356,6
8,22.0,Bone lesion,16120356,6
9,22.0,Fatigue,16120356,6
10,22.0,Metastases to central nervous system,16120356,6
11,22.0,Alopecia,16120356,6
12,22.0,Metastases to lung,16120356,1
13,22.0,Metastases to central nervous system,16120356,6
14,22.0,Bone lesion,16120356,6
15,22.0,Central nervous system lesion,16120356,6
16,22.0,Pulmonary embolism,16120356,6
17,22.0,Metastases to liver,16120356,1
0,22.0,Eructation,16120390,
1,22.0,Decreased appetite,16120390,3
2,22.0,Lung disorder,16120390,
3,22.0,Death,16120390,5
4,22.0,Diarrhoea,16120390,3
5,22.0,Fatigue,16120390,3
0,21.1,Neuralgia,16120423,3
1,21.1,Oedema,16120423,3
2,21.1,Anaemia,16120423,3
3,21.1,Muscular weakness,16120423,3
0,22.0,Bladder cancer,16120465,3
1,22.0,Product availability issue,16120465,6
0,22.1,Acute kidney injury,16120481,1
1,22.1,Confusional state,16120481,3
2,22.1,Septic shock,16120481,5
3,22.1,Inflammation,16120481,3
0,22.0,Refusal of treatment by patient,16120483,6
1,22.0,Wrong technique in product usage process,16120483,6
2,22.0,Therapy non-responder,16120483,6
3,22.0,White blood cell count decreased,16120483,6
0,22.0,Presyncope,16120584,1
0,21.1,Varices oesophageal,16120594,2
1,21.1,Venoocclusive liver disease,16120594,2
2,21.1,Portal hypertension,16120594,2
0,22.1,Interstitial lung disease,16120624,3
0,21.1,Erythema,16120625,6
1,21.1,Dry skin,16120625,6
2,21.1,Neuropathy peripheral,16120625,6
3,21.1,Off label use,16120625,6
4,21.1,Thrombocytopenia,16120625,1
5,21.1,Metastases to liver,16120625,3
6,21.1,Dermatitis acneiform,16120625,6
7,21.1,Mucosal inflammation,16120625,2
0,21.1,Colitis ischaemic,16120634,2
0,22.1,Bronchitis,16120643,1
1,22.1,Lymphopenia,16120643,1
2,22.1,Blood calcium increased,16120643,6
3,22.1,White blood cell count decreased,16120643,1
4,22.1,Neutropenia,16120643,1
5,22.1,Urinary tract infection,16120643,1
6,22.1,Blood creatinine increased,16120643,3
7,22.1,Depression,16120643,6
8,22.1,Vomiting,16120643,3
9,22.1,Fatigue,16120643,3
10,22.1,Intervertebral disc protrusion,16120643,3
11,22.1,Depressed mood,16120643,6
12,22.1,Viral infection,16120643,1
13,22.1,Diarrhoea,16120643,3
14,22.1,Pruritus,16120643,3
15,22.1,Anaemia,16120643,3
16,22.1,Nausea,16120643,3
17,22.1,Oedema peripheral,16120643,3
18,22.1,Electrocardiogram QT prolonged,16120643,1
19,22.1,Hypokalaemia,16120643,1
0,21.1,Cellulitis,16120652,6
0,21.1,Pruritus,16120655,1
1,21.1,Metastases to liver,16120655,6
2,21.1,Ejection fraction decreased,16120655,6
3,21.1,Erythema,16120655,6
4,21.1,Hypoaesthesia,16120655,6
5,21.1,Pruritus,16120655,1
6,21.1,Oedema peripheral,16120655,6
7,21.1,Polyneuropathy,16120655,6
8,21.1,Peripheral swelling,16120655,6
9,21.1,Metastases to lung,16120655,6
10,21.1,Hepatomegaly,16120655,6
0,21.1,Malignant neoplasm progression,16120659,5
0,21.1,Death,16120693,5
1,21.1,Hypothyroidism,16120693,6
0,21.1,Left ventricular dysfunction,16120694,1
0,21.1,Interstitial lung disease,16120702,6
0,22.0,Urinary tract infection,16120705,6
1,22.0,Nausea,16120705,6
2,22.0,Diarrhoea,16120705,6
3,22.0,Dehydration,16120705,6
0,21.1,Hypoalbuminaemia,16120706,6
1,21.1,Capillary leak syndrome,16120706,6
0,21.1,Death,16120744,5
0,22.1,Diabetes mellitus,16120778,1
0,21.1,Death,16120792,5
0,22.0,Overdose,16120807,5
0,21.1,Death,16120817,5
0,21.1,Epistaxis,16120840,6
1,21.1,Palpitations,16120840,6
2,21.1,Vascular stenosis,16120840,6
3,21.1,Gingival swelling,16120840,6
4,21.1,Feeling abnormal,16120840,6
5,21.1,Intestinal obstruction,16120840,6
6,21.1,Gingival bleeding,16120840,6
7,21.1,Hot flush,16120840,6
8,21.1,Renal cyst,16120840,6
9,21.1,Decreased appetite,16120840,6
10,21.1,Hypersomnia,16120840,6
11,21.1,Dizziness,16120840,6
12,21.1,Protein urine,16120840,6
13,21.1,Haemoptysis,16120840,6
14,21.1,Erythema,16120840,6
15,21.1,Head discomfort,16120840,3
16,21.1,Vasospasm,16120840,6
17,21.1,Fatigue,16120840,6
18,21.1,Vascular fragility,16120840,6
19,21.1,Blood pressure systolic increased,16120840,6
0,21.1,Agranulocytosis,16120884,1
0,21.1,Transient ischaemic attack,16120890,1
0,22.0,Bone disorder,16120904,6
1,22.0,Drug ineffective,16120904,6
0,21.1,Metastases to peritoneum,16120924,6
1,21.1,Adenocarcinoma of colon,16120924,6
0,22.0,Lung infection,16120944,1
1,22.0,Febrile neutropenia,16120944,1
2,22.0,Thrombocytopenia,16120944,6
0,21.1,Seizure,16120982,6
1,21.1,Ejection fraction decreased,16120982,6
2,21.1,Neutropenia,16120982,6
0,21.1,Hypertension,16120983,1
1,21.1,Subileus,16120983,1
2,21.1,Hypertension,16120983,1
0,22.0,Pneumonia,16121000,5
1,22.0,Sepsis,16121000,5
2,22.0,Breast cancer,16121000,5
3,22.0,Hepatic failure,16121000,5
4,22.0,Metastases to liver,16121000,5
0,21.1,Bronchitis,16121061,1
0,21.1,Platelet count decreased,16121087,3
1,21.1,Pneumonitis,16121087,3
2,21.1,Dermatitis exfoliative generalised,16121087,3
0,21.1,Dyspnoea,16121107,1
1,21.1,Chills,16121107,1
2,21.1,Hypoxia,16121107,1
0,21.1,Acute myeloid leukaemia,16121145,1
0,21.1,Pneumatosis intestinalis,16121153,6
1,21.1,Abdominal pain,16121153,2
0,21.1,Cancer pain,16121184,3
1,21.1,Drug ineffective,16121184,6
2,21.1,Spinal pain,16121184,3
3,21.1,Condition aggravated,16121184,3
0,21.1,Gastrointestinal toxicity,16121195,5
0,21.1,Acute myeloid leukaemia,16121204,3
0,22.0,Dizziness,16121215,6
1,22.0,Femoral neck fracture,16121215,6
2,22.0,Fall,16121215,6
0,21.1,Hypotension,16121219,1
1,21.1,Pyrexia,16121219,1
2,21.1,Back pain,16121219,1
0,21.1,Hot flush,16121223,1
1,21.1,Hypertension,16121223,1
2,21.1,Erythema,16121223,1
3,21.1,Sense of oppression,16121223,1
4,21.1,Infusion related reaction,16121223,1
0,21.1,Gastrointestinal disorder,16121232,1
1,21.1,Proteinuria,16121232,3
2,21.1,Gastrointestinal toxicity,16121232,6
0,22.0,Proctitis,16121233,6
1,22.0,Colitis,16121233,1
0,21.1,Transient ischaemic attack,16121238,1
0,21.1,Diarrhoea,16121241,1
1,21.1,Lower respiratory tract infection,16121241,6
2,21.1,Exercise tolerance decreased,16121241,6
3,21.1,Fatigue,16121241,6
4,21.1,Decreased appetite,16121241,6
5,21.1,Dyspnoea,16121241,6
0,22.0,Product prescribing issue,16121254,6
1,22.0,Product use in unapproved indication,16121254,6
2,22.0,Death,16121254,5
0,21.1,Paraesthesia,16121274,1
1,21.1,Paraesthesia oral,16121274,1
2,21.1,Dyspnoea,16121274,1
3,21.1,Dysphonia,16121274,1
0,21.1,Drug interaction,16121275,6
1,21.1,Transaminases increased,16121275,2
0,21.1,Off label use,16121290,6
1,21.1,Abdominal pain,16121290,2
2,21.1,Diarrhoea,16121290,2
0,21.1,Dyspnoea,16121292,2
1,21.1,Hypotension,16121292,2
2,21.1,Hypersensitivity,16121292,2
3,21.1,Loss of consciousness,16121292,2
4,21.1,Erythema,16121292,2
0,21.1,Dyspnoea,16121297,1
1,21.1,Loss of consciousness,16121297,1
0,22.0,Adverse reaction,16121302,6
1,22.0,Dizziness,16121302,6
2,22.0,Product substitution issue,16121302,6
3,22.0,Myalgia,16121302,6
4,22.0,Asthenia,16121302,6
0,21.1,Liver injury,16121318,6
0,22.0,Neurotoxicity,16121427,3
0,21.1,Agranulocytosis,16121429,1
0,21.1,Agranulocytosis,16121435,1
1,21.1,Leukopenia,16121435,1
0,21.1,Anaemia,16121447,3
1,21.1,Skin exfoliation,16121447,6
2,21.1,Hypoaesthesia,16121447,6
0,22.0,Terminal state,16121465,6
0,22.1,Alopecia,16121466,6
1,22.1,Radiation oesophagitis,16121466,6
2,22.1,Pneumonia bacterial,16121466,6
3,22.1,Febrile neutropenia,16121466,6
4,22.1,Therapeutic response decreased,16121466,6
5,22.1,Neutropenia,16121466,6
0,21.1,Stevens-Johnson syndrome,16121471,2
0,21.1,Infusion related reaction,16121475,1
1,21.1,Chills,16121475,1
2,21.1,Hypertension,16121475,1
3,21.1,Pyrexia,16121475,1
4,21.1,Tachycardia,16121475,1
0,21.1,Drug ineffective,16121482,6
1,21.1,Disease progression,16121482,6
2,21.1,Metastases to lung,16121482,6
3,21.1,Colorectal cancer metastatic,16121482,6
0,21.1,Laboratory test abnormal,16121519,6
1,21.1,Intestinal obstruction,16121519,6
2,21.1,Palmar-plantar erythrodysaesthesia syndrome,16121519,6
3,21.1,General physical health deterioration,16121519,2
0,21.1,Paraesthesia,16121551,1
1,21.1,Hot flush,16121551,1
2,21.1,Dyspnoea,16121551,1
3,21.1,Pharyngeal paraesthesia,16121551,1
0,22.1,Malignant neoplasm progression,16121554,5
1,22.1,Liver disorder,16121554,5
2,22.1,Colitis,16121554,6
0,22.0,Liver disorder,16121555,1
0,21.1,Skin exfoliation,16121560,6
1,21.1,Rash macular,16121560,6
2,21.1,Diarrhoea,16121560,6
3,21.1,Dry skin,16121560,6
0,22.0,Diarrhoea,16121563,6
0,22.0,Pancreatitis,16121591,1
1,22.0,Abdominal pain upper,16121591,1
2,22.0,Cholelithiasis,16121591,1
0,21.1,Febrile neutropenia,16121645,6
0,21.1,Peripheral pulse decreased,16121665,3
1,21.1,Muscle fatigue,16121665,3
2,21.1,Pain in extremity,16121665,3
3,21.1,Peripheral artery stenosis,16121665,3
4,21.1,Paraesthesia,16121665,3
5,21.1,Arthralgia,16121665,3
6,21.1,Sensory disturbance,16121665,3
7,21.1,Myalgia,16121665,3
8,21.1,Lividity,16121665,3
9,21.1,Intermittent claudication,16121665,3
0,22.1,Cerebral venous sinus thrombosis,16121670,2
0,21.1,Pain in jaw,16121678,3
1,21.1,Death,16121678,5
2,21.1,Abdominal pain upper,16121678,3
0,21.1,Renal impairment,16121679,6
1,21.1,Fistula discharge,16121679,1
2,21.1,Osteonecrosis of jaw,16121679,1
3,21.1,Blood creatinine abnormal,16121679,6
0,21.1,Incontinence,16121684,3
1,21.1,Micturition urgency,16121684,3
0,21.1,Death,16121806,5
0,21.1,Weight decreased,16121825,6
1,21.1,Peripheral swelling,16121825,6
2,21.1,Thrombophlebitis,16121825,6
0,22.0,Cyanosis,16121840,
1,22.0,Pulse absent,16121840,
2,22.0,Hypopnoea,16121840,
0,21.1,Headache,16121842,1
1,21.1,Hyperthermia,16121842,1
2,21.1,Infusion related reaction,16121842,1
3,21.1,Hypertension,16121842,1
4,21.1,Tremor,16121842,1
0,22.0,Pulmonary fibrosis,16121851,5
0,21.1,Alopecia,16121914,3
0,22.1,Impetigo,16121918,2
1,22.1,Radiation pneumonitis,16121918,1
0,21.1,Alopecia,16121960,6
1,21.1,Agitation,16121960,6
2,21.1,Depression,16121960,6
3,21.1,Toothache,16121960,6
4,21.1,Memory impairment,16121960,6
5,21.1,Arthralgia,16121960,6
0,22.0,Cardiac operation,16121967,
0,21.1,Hair disorder,16121987,3
1,21.1,Hair texture abnormal,16121987,3
2,21.1,Alopecia,16121987,3
3,21.1,Hair colour changes,16121987,3
4,21.1,Madarosis,16121987,3
0,22.0,Drug hypersensitivity,16122000,
1,22.0,Therapy cessation,16122000,
0,22.1,Product use in unapproved indication,16122074,6
1,22.1,Nasopharyngitis,16122074,2
2,22.1,Off label use,16122074,6
3,22.1,Seasonal allergy,16122074,6
4,22.1,Lacrimation increased,16122074,3
5,22.1,Dry eye,16122074,3
6,22.1,Oropharyngeal pain,16122074,1
7,22.1,Rhinorrhoea,16122074,2
8,22.1,Eye pruritus,16122074,3
0,22.0,Alopecia,16122111,3
1,22.0,Hair texture abnormal,16122111,3
2,22.0,Depression,16122111,6
3,22.0,Hair disorder,16122111,3
4,22.0,Hair colour changes,16122111,3
5,22.0,Madarosis,16122111,3
6,22.0,Anxiety,16122111,6
0,22.1,Neutropenia,16122131,6
1,22.1,Renal function test abnormal,16122131,6
2,22.1,Neoplasm progression,16122131,6
0,22.0,Interstitial lung disease,16122185,5
0,22.0,Neutrophil count decreased,16122197,1
0,21.1,Death,16122211,5
0,21.1,Hypokalaemia,16122250,3
1,21.1,Cardiogenic shock,16122250,5
2,21.1,Cough,16122250,1
3,21.1,Acute kidney injury,16122250,5
4,21.1,Dyspnoea,16122250,3
5,21.1,Pneumonia,16122250,5
6,21.1,Pyrexia,16122250,1
0,21.1,Gastrointestinal haemorrhage,16122251,1
1,21.1,Cholelithiasis,16122251,1
2,21.1,Abdominal pain,16122251,1
3,21.1,Anaemia,16122251,1
4,21.1,Cholangitis,16122251,1
0,22.0,Blood creatinine increased,16122261,2
1,22.0,Respiratory failure,16122261,2
2,22.0,PCO2 decreased,16122261,1
3,22.0,Oxygen saturation decreased,16122261,1
4,22.0,Pulmonary toxicity,16122261,2
5,22.0,C-reactive protein increased,16122261,1
6,22.0,Blood lactate dehydrogenase increased,16122261,2
7,22.0,Fatigue,16122261,2
8,22.0,Respiratory distress,16122261,2
9,22.0,Blood urea increased,16122261,2
10,22.0,Blood sodium decreased,16122261,1
0,22.0,Hepatotoxicity,16122275,1
1,22.0,Immune-mediated adverse reaction,16122275,6
2,22.0,Hyperbilirubinaemia,16122275,6
3,22.0,Off label use,16122275,6
0,21.1,Loss of libido,16122286,2
1,21.1,Muscle fatigue,16122286,2
2,21.1,Muscle atrophy,16122286,2
3,21.1,Hot flush,16122286,2
4,21.1,Osteopenia,16122286,2
0,21.1,Toxicity to various agents,16122301,5
0,21.1,Gait disturbance,16122351,2
1,21.1,Groin pain,16122351,6
2,21.1,Osteonecrosis,16122351,2
0,21.1,Vomiting,16122383,6
1,21.1,Back pain,16122383,6
2,21.1,Nausea,16122383,6
3,21.1,Musculoskeletal chest pain,16122383,6
0,21.1,Terminal state,16122394,6
0,21.1,Dysgeusia,16122416,6
0,22.0,Death,16122417,
0,22.0,Pulmonary mass,16122429,
1,22.0,Pleural effusion,16122429,
2,22.0,Lung neoplasm malignant,16122429,
3,22.0,Apnoea,16122429,
4,22.0,Hypotension,16122429,
5,22.0,Pulse absent,16122429,
6,22.0,Neoplasm progression,16122429,
7,22.0,Breath sounds absent,16122429,
8,22.0,Diarrhoea,16122429,
9,22.0,Bandaemia,16122429,
10,22.0,Unresponsive to stimuli,16122429,
11,22.0,Tachycardia,16122429,
12,22.0,Sepsis,16122429,
0,22.0,Ventricular hypokinesia,16122434,1
0,21.1,Arthritis bacterial,16122445,6
1,21.1,Scratch,16122445,6
2,21.1,Staphylococcal infection,16122445,6
3,21.1,Musculoskeletal pain,16122445,6
4,21.1,Peripheral swelling,16122445,6
5,21.1,Fall,16122445,6
6,21.1,Swelling,16122445,6
7,21.1,Arthralgia,16122445,6
8,21.1,Pain in extremity,16122445,6
0,22.0,Diarrhoea,16122447,6
1,22.0,Weight decreased,16122447,6
2,22.0,Back pain,16122447,6
3,22.0,Blood alkaline phosphatase increased,16122447,6
4,22.0,Osteonecrosis of jaw,16122447,6
5,22.0,Blood pressure increased,16122447,1
6,22.0,Vomiting,16122447,6
7,22.0,Aspartate aminotransferase increased,16122447,6
8,22.0,Palmar-plantar erythrodysaesthesia syndrome,16122447,1
9,22.0,Oral pain,16122447,6
10,22.0,Glomerular filtration rate decreased,16122447,6
11,22.0,Pain,16122447,6
12,22.0,Red cell distribution width increased,16122447,6
13,22.0,Carbon dioxide decreased,16122447,6
14,22.0,Stomatitis,16122447,1
15,22.0,Skin lesion,16122447,6
16,22.0,Arthralgia,16122447,6
17,22.0,Appetite disorder,16122447,6
18,22.0,Mean cell haemoglobin decreased,16122447,6
19,22.0,Blood calcium increased,16122447,6
20,22.0,Cough,16122447,6
21,22.0,Fatigue,16122447,6
0,21.1,Death,16122468,5
1,21.1,Hypophysitis,16122468,6
0,22.1,Tracheitis,16122542,1
0,21.1,Skin exfoliation,16122580,1
1,21.1,Xerosis,16122580,1
2,21.1,Eczema,16122580,1
0,21.1,Tonsillitis,16122581,6
1,21.1,Pallor,16122581,6
2,21.1,Mouth ulceration,16122581,6
3,21.1,Faeces discoloured,16122581,6
4,21.1,Hyponatraemia,16122581,6
5,21.1,Erythema,16122581,6
6,21.1,Acute kidney injury,16122581,6
7,21.1,Productive cough,16122581,6
8,21.1,Somnolence,16122581,6
9,21.1,Diarrhoea,16122581,6
10,21.1,Unresponsive to stimuli,16122581,6
11,21.1,Malaise,16122581,6
12,21.1,Pruritus,16122581,6
13,21.1,Hypovolaemia,16122581,6
14,21.1,Confusional state,16122581,6
0,21.1,Weight decreased,16122616,6
0,21.1,Hypokalaemia,16122632,6
1,21.1,Seizure,16122632,6
2,21.1,Hepatic function abnormal,16122632,6
0,22.0,Respiratory tract infection,16122634,1
0,21.1,Rash pruritic,16122656,3
0,22.0,Disease progression,16122667,1
1,22.0,Diarrhoea,16122667,6
2,22.0,Therapeutic response decreased,16122667,1
3,22.0,HER-2 positive gastric cancer,16122667,1
0,22.0,Impaired quality of life,16122688,6
1,22.0,Anxiety,16122688,6
2,22.0,Psychological trauma,16122688,6
3,22.0,Alopecia,16122688,2
4,22.0,Emotional distress,16122688,6
5,22.0,Pain,16122688,6
0,22.0,Alopecia,16122689,2
1,22.0,Psychological trauma,16122689,6
0,22.0,Alopecia,16122693,2
1,22.0,Impaired quality of life,16122693,6
2,22.0,Psychological trauma,16122693,6
3,22.0,Emotional distress,16122693,6
4,22.0,Anxiety,16122693,6
5,22.0,Pain,16122693,6
0,22.0,Alopecia,16122699,3
1,22.0,Emotional distress,16122699,6
2,22.0,Anxiety,16122699,6
3,22.0,Impaired quality of life,16122699,6
4,22.0,Pain,16122699,6
5,22.0,Psychological trauma,16122699,6
0,21.1,Off label use,16122745,6
1,21.1,Product use in unapproved indication,16122745,6
2,21.1,Bronchitis,16122745,4
0,21.1,Death,16122781,5
0,22.0,Intentional product use issue,16122864,6
1,22.0,Impaired healing,16122864,6
2,22.0,Adverse event,16122864,6
3,22.0,Diarrhoea,16122864,6
4,22.0,Alopecia,16122864,6
0,21.1,Incorrect dose administered,16122888,6
0,21.1,Thrombophlebitis superficial,16122963,2
1,21.1,Deep vein thrombosis,16122963,2
0,22.0,Palpitations,16122986,6
1,22.0,Dizziness exertional,16122986,6
2,22.0,Osteoarthritis,16122986,6
3,22.0,Nausea,16122986,6
0,22.0,Acute hepatic failure,16123008,5
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,16123008,2
2,22.0,Jaundice,16123008,5
3,22.0,Palmar-plantar erythrodysaesthesia syndrome,16123008,2
4,22.0,Depressed level of consciousness,16123008,
5,22.0,Liver disorder,16123008,5
6,22.0,Aspartate aminotransferase increased,16123008,5
7,22.0,Bradycardia,16123008,
8,22.0,Hypertension,16123008,
9,22.0,Coma,16123008,
10,22.0,Hyperbilirubinaemia,16123008,5
11,22.0,Hepatic encephalopathy,16123008,
12,22.0,Cardiac arrest,16123008,
13,22.0,Hypertension,16123008,2
14,22.0,Chest discomfort,16123008,
0,21.1,Death,16123082,5
0,22.0,Spinal compression fracture,16123155,3
1,22.0,Fall,16123155,6
2,22.0,Confusional state,16123155,6
3,22.0,General physical health deterioration,16123155,6
4,22.0,Urosepsis,16123155,1
5,22.0,Blood urine present,16123155,6
0,21.1,Haemorrhage,16123160,6
0,22.0,Infective aortitis,16123205,2
1,22.0,Pyrexia,16123205,2
2,22.0,Bacteraemia,16123205,6
0,22.0,Pyrexia,16123210,2
1,22.0,Bacteraemia,16123210,6
2,22.0,Infective aortitis,16123210,2
0,21.1,Fistula,16123226,1
0,21.1,Chronic kidney disease,16123250,1
0,22.0,Lung infection,16123261,1
1,22.0,Ulcer haemorrhage,16123261,1
0,22.0,Aortic dissection,16123280,3
1,22.0,Blood pressure increased,16123280,1
2,22.0,Abdominal pain upper,16123280,3
0,22.0,Drug intolerance,16123310,6
1,22.0,Nausea,16123310,6
2,22.0,Mucosal inflammation,16123310,6
3,22.0,Stomatitis,16123310,6
4,22.0,Vomiting,16123310,6
0,21.1,Interstitial lung disease,16123321,2
0,21.1,Chemotherapy,16123347,6
0,22.0,Acute myeloid leukaemia,16123348,5
1,22.0,Splenomegaly,16123348,3
2,22.0,Pyrexia,16123348,3
3,22.0,Haemodynamic instability,16123348,3
4,22.0,Diffuse large B-cell lymphoma,16123348,5
5,22.0,Headache,16123348,3
6,22.0,Oxygen saturation decreased,16123348,3
7,22.0,Candida infection,16123348,3
8,22.0,Pneumonia fungal,16123348,5
9,22.0,Respiratory failure,16123348,5
10,22.0,Cytopenia,16123348,3
11,22.0,Febrile neutropenia,16123348,3
12,22.0,Lymphoma,16123348,3
13,22.0,Encephalopathy,16123348,3
14,22.0,Off label use,16123348,3
0,21.1,Adrenocorticotropic hormone deficiency,16123375,6
1,21.1,Hypopituitarism,16123375,6
0,22.0,Pleural effusion,16123430,1
0,21.1,Death,16123431,5
0,22.0,Ejection fraction decreased,16123434,1
1,22.0,Decreased appetite,16123434,6
2,22.0,Proteinuria,16123434,6
0,22.0,Pain in jaw,16123446,6
1,22.0,Diarrhoea,16123446,6
2,22.0,Decreased appetite,16123446,1
3,22.0,Fatigue,16123446,1
4,22.0,Clostridium difficile colitis,16123446,6
5,22.0,Neutropenia,16123446,6
6,22.0,Drug ineffective,16123446,6
7,22.0,Hypertension,16123446,6
8,22.0,Abdominal pain,16123446,6
0,21.1,Neutropenia,16123456,6
1,21.1,Off label use,16123456,6
2,21.1,Intentional product use issue,16123456,6
0,22.1,Radiation pneumonitis,16123461,1
1,22.1,Diarrhoea,16123461,3
2,22.1,Intestinal metastasis,16123461,6
0,21.1,Death,16123504,5
0,21.1,Dermatitis bullous,16123520,3
0,22.1,Neutropenia,16123569,1
1,22.1,Pneumonia pneumococcal,16123569,5
2,22.1,Influenza,16123569,1
3,22.1,Flavobacterium infection,16123569,5
0,22.0,Interstitial lung disease,16123573,2
1,22.0,Productive cough,16123573,6
0,22.0,Interstitial lung disease,16123601,2
0,21.1,Atrial fibrillation,16123640,6
1,21.1,Pneumonitis,16123640,6
2,21.1,Hyperthyroidism,16123640,6
0,21.1,Pulmonary embolism,16123644,6
1,21.1,Death,16123644,5
2,21.1,Malaise,16123644,6
0,22.0,Ischaemic stroke,16123650,4
0,21.1,Hair texture abnormal,16123675,3
1,21.1,Hair disorder,16123675,3
2,21.1,Alopecia,16123675,3
3,21.1,Hair colour changes,16123675,3
0,21.1,Hair texture abnormal,16123684,3
1,21.1,Hair disorder,16123684,3
2,21.1,Alopecia,16123684,3
3,21.1,Hair colour changes,16123684,3
0,22.0,Colitis,16123704,1
0,21.1,Neoplasm progression,16123733,6
1,21.1,Hyperbilirubinaemia,16123733,6
2,21.1,Thrombocytopenia,16123733,6
0,21.1,Hair texture abnormal,16123734,3
1,21.1,Madarosis,16123734,3
2,21.1,Alcoholism,16123734,6
3,21.1,Hair colour changes,16123734,3
4,21.1,Depression,16123734,6
5,21.1,Alopecia,16123734,3
6,21.1,Hair disorder,16123734,3
0,22.0,Rhinorrhoea,16123755,3
1,22.0,Neutropenia,16123755,1
2,22.0,Lower respiratory tract infection,16123755,1
3,22.0,Lacrimation increased,16123755,3
4,22.0,Haemoglobin decreased,16123755,1
5,22.0,Ejection fraction decreased,16123755,3
0,21.1,Haemoglobin decreased,16123765,3
1,21.1,Ascites,16123765,3
2,21.1,Haemorrhage,16123765,6
3,21.1,Hypertension,16123765,3
4,21.1,Delirium,16123765,6
5,21.1,Faecaloma,16123765,1
6,21.1,Subileus,16123765,1
7,21.1,Pyrexia,16123765,3
8,21.1,Abscess,16123765,5
9,21.1,Faecaloma,16123765,1
10,21.1,Wound infection,16123765,3
11,21.1,Wound haemorrhage,16123765,3
12,21.1,Proctalgia,16123765,3
13,21.1,Anaemia,16123765,6
0,22.0,Dyspnoea at rest,16123767,2
0,22.0,Pneumonia,16123774,1
1,22.0,Blood pressure increased,16123774,6
2,22.0,Pyrexia,16123774,6
3,22.0,Sepsis,16123774,1
4,22.0,Confusional state,16123774,6
5,22.0,Product use in unapproved indication,16123774,6
0,21.1,Alopecia,16123813,3
1,21.1,Hair colour changes,16123813,3
2,21.1,Hair disorder,16123813,3
3,21.1,Hair texture abnormal,16123813,3
4,21.1,Madarosis,16123813,3
0,22.0,Dementia Alzheimer^s type,16123830,3
1,22.0,Metastasis,16123830,3
2,22.0,Dyspnoea,16123830,5
0,22.0,Alanine aminotransferase increased,16123867,2
1,22.0,Drug-induced liver injury,16123867,6
2,22.0,Aspartate aminotransferase increased,16123867,2
0,21.1,Retinal tear,16123870,6
0,21.1,Colitis,16123881,2
0,21.1,Limb injury,16123883,3
1,21.1,Off label use,16123883,1
2,21.1,Tooth loss,16123883,1
0,22.0,Interstitial lung disease,16123886,2
0,22.0,Osteoarthritis,16123891,6
1,22.0,Thrombotic cerebral infarction,16123891,3
2,22.0,Pulmonary infarction,16123891,4
0,21.1,Haemorrhagic transformation stroke,16123894,2
0,22.0,Metastases to bone,16123895,6
1,22.0,Metastases to skin,16123895,6
2,22.0,Metastases to liver,16123895,6
0,22.0,Agranulocytosis,16123931,2
1,22.0,Mouth ulceration,16123931,2
0,21.1,Intestinal dilatation,16123932,6
1,21.1,Intestinal obstruction,16123932,6
2,21.1,Gallbladder disorder,16123932,6
3,21.1,Defaecation disorder,16123932,6
4,21.1,Liver disorder,16123932,6
5,21.1,Cholelithiasis,16123932,6
0,22.0,Anaphylactic shock,16123971,1
0,22.0,Anaphylactic shock,16124074,1
0,21.1,Hepatitis acute,16124082,2
0,21.1,Acute myeloid leukaemia,16124089,3
0,21.1,Dermatitis acneiform,16124092,1
0,22.0,Asthenia,16124104,2
1,22.0,Cough,16124104,2
2,22.0,Weight decreased,16124104,2
3,22.0,Interstitial lung disease,16124104,2
4,22.0,Erythema,16124104,2
5,22.0,Oedema,16124104,2
6,22.0,Hyperpyrexia,16124104,2
7,22.0,Dyspnoea,16124104,2
8,22.0,Fluid retention,16124104,2
0,21.1,Retinal artery thrombosis,16124111,1
1,21.1,Neutrophil count decreased,16124111,6
0,21.1,Rash generalised,16124164,1
1,21.1,Infusion related reaction,16124164,1
2,21.1,Ear discomfort,16124164,1
3,21.1,Feeling abnormal,16124164,1
0,21.1,Agranulocytosis,16124169,1
0,21.1,Liver injury,16124173,2
1,21.1,Jaundice cholestatic,16124173,2
0,21.1,Leukopenia,16124174,1
1,21.1,Agranulocytosis,16124174,1
0,22.0,Cerebrovascular accident,16124175,3
1,22.0,Dyspepsia,16124175,2
2,22.0,Weight decreased,16124175,2
3,22.0,Asthenia,16124175,2
4,22.0,Dry skin,16124175,1
5,22.0,Decreased appetite,16124175,2
6,22.0,Blister,16124175,1
7,22.0,Thyroglobulin increased,16124175,3
8,22.0,Diarrhoea,16124175,3
9,22.0,Blood thyroid stimulating hormone increased,16124175,3
0,22.0,Oral cavity fistula,16124193,2
1,22.0,Osteonecrosis of jaw,16124193,2
0,21.1,Drug ineffective,16124204,6
1,21.1,Prostatic specific antigen increased,16124204,6
0,21.1,Malignant neoplasm progression,16124205,6
0,22.0,Disease progression,16124207,6
0,21.1,Prostatic specific antigen increased,16124208,6
1,21.1,Neoplasm progression,16124208,6
0,21.1,Secretion discharge,16124210,3
1,21.1,Cough,16124210,3
2,21.1,Hot flush,16124210,3
3,21.1,Weight increased,16124210,3
4,21.1,Hyperhidrosis,16124210,3
0,21.1,Prostatic specific antigen increased,16124211,3
0,21.1,Prostatic specific antigen increased,16124212,6
0,21.1,Blood testosterone increased,16124213,3
1,21.1,Hot flush,16124213,3
2,21.1,Prostatic specific antigen increased,16124213,3
0,21.1,Prostatic specific antigen increased,16124214,6
1,21.1,Disease progression,16124214,6
0,21.1,Prostatic specific antigen increased,16124215,3
0,21.1,Drug ineffective,16124216,6
1,21.1,Malignant neoplasm progression,16124216,6
0,21.1,Disease progression,16124217,6
0,22.0,Disease progression,16124218,6
1,22.0,Drug ineffective,16124218,6
0,21.1,Prostatic specific antigen increased,16124219,6
0,21.1,Disease progression,16124220,6
1,21.1,Drug ineffective,16124220,6
0,21.1,Prostatic specific antigen increased,16124221,3
0,21.1,Arthritis,16124226,6
1,21.1,Rash,16124226,2
2,21.1,Dysstasia,16124226,6
0,21.1,Haemolytic anaemia,16124227,6
0,22.0,Small intestinal haemorrhage,16124241,1
1,22.0,Proteinuria,16124241,6
0,21.1,Oesophagitis,16124252,6
1,21.1,Gastritis,16124252,1
0,21.1,Stoma site infection,16124253,1
0,22.0,Vomiting,16124261,2
1,22.0,Weight decreased,16124261,6
0,22.0,Renal failure,16124262,1
0,22.1,Pneumonia,16124290,1
1,22.1,Leukopenia,16124290,1
2,22.1,Syncope,16124290,1
3,22.1,Neutropenia,16124290,1
4,22.1,Neutropenia,16124290,3
0,21.1,Dyspnoea,16124313,6
1,21.1,Swelling face,16124313,6
2,21.1,Diarrhoea,16124313,6
0,21.1,Death,16124314,5
0,22.1,Wound complication,16124377,1
1,22.1,Ileus,16124377,6
2,22.1,Nausea,16124377,1
3,22.1,Hypothyroidism,16124377,1
0,22.0,Emotional distress,16124403,6
1,22.0,Pain,16124403,6
2,22.0,Psychological trauma,16124403,6
3,22.0,Alopecia,16124403,2
4,22.0,Anxiety,16124403,6
5,22.0,Impaired quality of life,16124403,6
0,22.0,Alopecia,16124406,2
1,22.0,Anxiety,16124406,6
2,22.0,Emotional distress,16124406,6
0,22.0,Alopecia,16124420,2
1,22.0,Anxiety,16124420,6
2,22.0,Impaired quality of life,16124420,6
3,22.0,Psychological trauma,16124420,6
4,22.0,Pain,16124420,6
5,22.0,Emotional distress,16124420,6
0,22.0,Alopecia,16124421,2
1,22.0,Emotional distress,16124421,6
2,22.0,Psychological trauma,16124421,6
0,21.1,Alopecia,16124445,2
1,21.1,Psychological trauma,16124445,6
0,22.0,Alopecia,16124447,2
1,22.0,Anxiety,16124447,6
2,22.0,Emotional distress,16124447,6
0,22.0,Anxiety,16124463,6
1,22.0,Alopecia,16124463,2
2,22.0,Emotional distress,16124463,6
3,22.0,Psychological trauma,16124463,6
0,21.1,Portal vein thrombosis,16124532,1
0,22.1,Blood count abnormal,16124537,6
0,21.1,Solar lentigo,16124592,6
1,21.1,Metastases to lung,16124592,6
0,21.1,Leukoencephalopathy,16124609,6
0,22.0,Abdominal pain upper,16124612,1
1,22.0,Acne,16124612,3
2,22.0,Asthenia,16124612,3
3,22.0,Dry skin,16124612,2
4,22.0,Product use in unapproved indication,16124612,3
5,22.0,Fatigue,16124612,3
0,21.1,Thrombocytopenia,16124647,6
1,21.1,Chronic kidney disease,16124647,6
2,21.1,Anaemia,16124647,6
0,22.0,Death,16124670,5
1,22.0,Bacterial infection,16124670,6
2,22.0,Stomatitis,16124670,6
3,22.0,Alopecia,16124670,6
4,22.0,Red blood cell count decreased,16124670,6
5,22.0,White blood cell count decreased,16124670,6
6,22.0,Fatigue,16124670,6
0,22.0,Steatohepatitis,16124679,3
1,22.0,Condition aggravated,16124679,3
0,21.1,Ovarian cancer recurrent,16124685,6
1,21.1,Product use in unapproved indication,16124685,6
0,22.0,Urine phosphorus abnormal,16124688,6
1,22.0,Diabetes mellitus,16124688,6
2,22.0,Decreased appetite,16124688,6
3,22.0,Fatigue,16124688,6
4,22.0,Metabolic acidosis,16124688,6
5,22.0,Hypophosphataemia,16124688,6
6,22.0,Hypokalaemia,16124688,6
7,22.0,Urine analysis abnormal,16124688,6
8,22.0,Pyrexia,16124688,3
9,22.0,Hypocalcaemia,16124688,6
10,22.0,Renal tubular acidosis,16124688,6
11,22.0,Aminoaciduria,16124688,6
12,22.0,Glycosuria,16124688,6
13,22.0,Malignant neoplasm progression,16124688,6
14,22.0,Fanconi syndrome acquired,16124688,1
15,22.0,Renal tubular dysfunction,16124688,6
16,22.0,Albumin urine present,16124688,6
17,22.0,Hypouricaemia,16124688,6
18,22.0,Blood potassium decreased,16124688,6
19,22.0,Beta 2 microglobulin urine abnormal,16124688,6
20,22.0,Dehydration,16124688,6
21,22.0,Renal impairment,16124688,6
22,22.0,Breast cancer,16124688,6
23,22.0,Glucose urine,16124688,6
0,21.1,Death,16124736,5
0,21.1,Neutropenia,16124737,1
0,22.0,Bronchospasm,16124738,1
1,22.0,Tachycardia,16124738,1
2,22.0,Syncope,16124738,1
3,22.0,Peripheral vascular disorder,16124738,1
4,22.0,Vomiting,16124738,1
0,21.1,Multiple organ dysfunction syndrome,16124742,5
0,22.0,Hepatic function abnormal,16124784,2
1,22.0,Blood thyroid stimulating hormone increased,16124784,2
2,22.0,Pleural effusion,16124784,1
0,21.1,Drug interaction,16124791,6
1,21.1,Disease progression,16124791,6
2,21.1,Diarrhoea,16124791,3
3,21.1,Asthenia,16124791,3
4,21.1,Nausea,16124791,3
5,21.1,Back pain,16124791,3
6,21.1,Dysgeusia,16124791,3
7,21.1,Intestinal obstruction,16124791,2
8,21.1,Decreased appetite,16124791,3
9,21.1,Loss of personal independence in daily activities,16124791,3
10,21.1,Pain,16124791,3
11,21.1,Vomiting,16124791,6
12,21.1,Therapy cessation,16124791,6
13,21.1,Contusion,16124791,3
14,21.1,Malaise,16124791,3
15,21.1,Gingival bleeding,16124791,3
16,21.1,Poor quality sleep,16124791,3
17,21.1,Apathy,16124791,3
18,21.1,Abdominal pain upper,16124791,1
19,21.1,Flatulence,16124791,3
20,21.1,Sleep deficit,16124791,3
21,21.1,Fatigue,16124791,3
0,22.0,Fatigue,16124795,3
1,22.0,Dyspnoea,16124795,3
2,22.0,Respiratory distress,16124795,6
3,22.0,Oxygen saturation decreased,16124795,3
0,22.0,Product use issue,16124851,1
1,22.0,Fall,16124851,6
2,22.0,Femoral neck fracture,16124851,6
3,22.0,Off label use,16124851,1
0,21.1,Gastric neoplasm,16124866,3
1,21.1,Haemangioma of liver,16124866,6
2,21.1,Periarthritis,16124866,6
3,21.1,Abdominal pain upper,16124866,6
4,21.1,Off label use,16124866,6
5,21.1,Pancreatic neoplasm,16124866,3
6,21.1,Pain,16124866,6
7,21.1,Dyspepsia,16124866,6
8,21.1,Depression,16124866,6
9,21.1,Headache,16124866,6
10,21.1,Fatigue,16124866,6
11,21.1,Decreased appetite,16124866,6
12,21.1,Parosmia,16124866,6
13,21.1,Malaise,16124866,6
14,21.1,Nausea,16124866,6
15,21.1,Pyrexia,16124866,6
16,21.1,Muscle spasms,16124866,6
17,21.1,Product use in unapproved indication,16124866,6
18,21.1,Metastases to peritoneum,16124866,6
19,21.1,Pain in extremity,16124866,6
20,21.1,Breast pain,16124866,6
21,21.1,Vomiting,16124866,6
0,22.0,Alopecia,16124950,3
1,22.0,Hair texture abnormal,16124950,3
2,22.0,Madarosis,16124950,3
3,22.0,Hair disorder,16124950,3
4,22.0,Hair colour changes,16124950,3
0,21.1,Hair colour changes,16124960,3
1,21.1,Madarosis,16124960,3
2,21.1,Hair disorder,16124960,3
3,21.1,Hair texture abnormal,16124960,3
4,21.1,Alopecia,16124960,3
0,22.0,Hair colour changes,16124961,3
1,22.0,Hair texture abnormal,16124961,3
2,22.0,Alopecia,16124961,3
3,22.0,Hair disorder,16124961,3
0,22.0,Pericarditis,16124964,1
0,22.1,Diabetic nephropathy,16124965,3
0,22.0,Gastric ulcer,16124991,6
1,22.0,Condition aggravated,16124991,6
2,22.0,Anaemia,16124991,6
3,22.0,Interstitial lung disease,16124991,3
0,21.1,Hair texture abnormal,16124993,3
1,21.1,Hair colour changes,16124993,3
2,21.1,Madarosis,16124993,3
3,21.1,Alopecia,16124993,3
4,21.1,Hair disorder,16124993,3
5,21.1,Mental disorder,16124993,6
6,21.1,Depression,16124993,6
0,22.0,Hair disorder,16124998,3
1,22.0,Hair colour changes,16124998,3
2,22.0,Hair texture abnormal,16124998,3
3,22.0,Alopecia,16124998,3
0,21.1,Alopecia,16124999,3
1,21.1,Hair texture abnormal,16124999,3
2,21.1,Depression,16124999,6
3,21.1,Hair colour changes,16124999,3
4,21.1,Madarosis,16124999,3
5,21.1,Hair disorder,16124999,3
0,22.0,Hospitalisation,16125032,6
1,22.0,Product use in unapproved indication,16125032,6
0,21.1,Thyroiditis subacute,16125044,1
0,22.0,Non-cirrhotic portal hypertension,16125056,6
0,22.1,Neoplasm progression,16125092,6
1,22.1,Pyrexia,16125092,6
2,22.1,Alopecia,16125092,6
3,22.1,White blood cell count decreased,16125092,3
4,22.1,Nasopharyngitis,16125092,6
0,21.1,Malignant neoplasm progression,16125104,6
1,21.1,Breast cancer metastatic,16125104,6
0,21.1,Diarrhoea,16125196,3
0,22.0,White blood cell count decreased,16125197,3
1,22.0,Vaginal disorder,16125197,6
2,22.0,Musculoskeletal pain,16125197,6
3,22.0,Neutropenia,16125197,3
4,22.0,Arthralgia,16125197,6
5,22.0,Dyspnoea,16125197,6
6,22.0,Decreased immune responsiveness,16125197,6
0,21.1,Urinary tract infection,16125222,6
1,21.1,Platelet count decreased,16125222,3
2,21.1,Vomiting,16125222,6
3,21.1,Respiratory tract infection,16125222,6
0,21.1,Non-small cell lung cancer,16125227,5
1,21.1,Intestinal obstruction,16125227,5
2,21.1,Malignant neoplasm progression,16125227,5
0,21.1,Blood count abnormal,16125250,2
1,21.1,Fall,16125250,6
2,21.1,Anaemia,16125250,2
3,21.1,Product dose omission,16125250,6
0,22.0,Malignant neoplasm progression,16125273,1
0,22.0,Oropharyngeal pain,16125379,3
1,22.0,Malaise,16125379,3
2,22.0,Device malfunction,16125379,6
3,22.0,Intentional device misuse,16125379,1
0,22.0,Oxygen saturation decreased,16125392,1
1,22.0,Pyrexia,16125392,1
2,22.0,Tremor,16125392,1
0,21.1,Agranulocytosis,16125399,1
0,22.1,Pneumonia,16125401,4
1,22.1,Product use issue,16125401,6
2,22.1,Diabetic ketoacidosis,16125401,1
3,22.1,Sepsis,16125401,1
4,22.1,Pneumonia,16125401,1
0,22.0,Product use issue,16125421,6
1,22.0,Ejection fraction decreased,16125421,1
2,22.0,Osteonecrosis of jaw,16125421,3
0,22.0,Thrombocytopenia,16125479,1
1,22.0,Neutropenia,16125479,1
0,22.1,Leukopenia,16125481,3
1,22.1,Diarrhoea,16125481,1
0,21.1,Transaminases increased,16125484,2
1,21.1,Infection,16125484,6
0,22.0,Hyperthermia,16125560,1
1,22.0,Malaise,16125560,1
2,22.0,Loss of consciousness,16125560,1
3,22.0,Tachycardia,16125560,1
0,21.1,Hepatotoxicity,16125587,6
1,21.1,Neutropenia,16125587,6
0,21.1,Asthenia,16125623,6
1,21.1,Dyspnoea,16125623,6
2,21.1,Cardiac failure congestive,16125623,6
3,21.1,Oedema,16125623,6
4,21.1,Fluid overload,16125623,6
0,22.0,Cystitis haemorrhagic,16125626,2
0,22.0,Fistula discharge,16125701,1
1,22.0,Renal impairment,16125701,6
2,22.0,Oral cavity fistula,16125701,1
3,22.0,Osteonecrosis of jaw,16125701,2
0,22.1,Cardiotoxicity,16125748,6
1,22.1,Ejection fraction decreased,16125748,1
0,21.1,Acute kidney injury,16125770,3
1,21.1,Pancytopenia,16125770,3
0,21.1,Insomnia,16125798,3
1,21.1,Asthenia,16125798,3
2,21.1,Nausea,16125798,3
3,21.1,Anxiety,16125798,3
0,22.0,Leukoencephalopathy,16125800,2
0,22.0,Weight fluctuation,16125820,6
0,21.1,Pain in jaw,16125821,6
1,21.1,Alveolar osteitis,16125821,6
2,21.1,Nausea,16125821,6
3,21.1,Pain in extremity,16125821,3
4,21.1,Gastrointestinal disorder,16125821,6
5,21.1,Osteoporosis,16125821,3
0,21.1,Paraesthesia,16125824,1
1,21.1,Dyspnoea,16125824,1
2,21.1,Hot flush,16125824,1
3,21.1,Pharyngeal paraesthesia,16125824,1
0,22.1,Nephrolithiasis,16125912,6
1,22.1,Lethargy,16125912,6
2,22.1,Urinary tract infection,16125912,6
0,21.1,Agranulocytosis,16125943,1
0,22.0,Constipation,16125963,6
1,22.0,Erythema,16125963,3
2,22.0,Ocular hyperaemia,16125963,3
3,22.0,Peripheral swelling,16125963,3
4,22.0,Influenza,16125963,6
0,21.1,Diarrhoea,16125966,1
1,21.1,General physical condition abnormal,16125966,1
2,21.1,Decreased appetite,16125966,1
0,21.1,Aspartate aminotransferase increased,16125968,2
1,21.1,Alanine aminotransferase increased,16125968,2
0,22.0,Hypertransaminasaemia,16126064,1
0,21.1,Pancytopenia,16126066,3
1,21.1,Acute kidney injury,16126066,3
0,22.1,Memory impairment,16126092,3
1,22.1,Decreased appetite,16126092,3
2,22.1,Oral pain,16126092,3
3,22.1,Peripheral coldness,16126092,3
4,22.1,Product odour abnormal,16126092,6
5,22.1,Dysgeusia,16126092,3
6,22.1,Parosmia,16126092,3
7,22.1,Dry mouth,16126092,3
8,22.1,Weight decreased,16126092,3
9,22.1,Neuropathy peripheral,16126092,3
10,22.1,Skin discolouration,16126092,3
0,22.0,Neurotoxicity,16126156,2
0,22.0,Alopecia,16126183,2
1,22.0,Anxiety,16126183,6
2,22.0,Emotional distress,16126183,6
0,22.0,Pain,16126221,6
1,22.0,Alopecia,16126221,2
2,22.0,Anxiety,16126221,6
3,22.0,Emotional distress,16126221,6
4,22.0,Impaired quality of life,16126221,6
5,22.0,Psychological trauma,16126221,6
0,22.0,Impaired quality of life,16126225,6
1,22.0,Alopecia,16126225,2
2,22.0,Anxiety,16126225,6
3,22.0,Pain,16126225,6
4,22.0,Psychological trauma,16126225,6
5,22.0,Emotional distress,16126225,6
0,22.0,Pain,16126239,6
1,22.0,Anxiety,16126239,6
2,22.0,Impaired quality of life,16126239,6
3,22.0,Psychological trauma,16126239,6
4,22.0,Alopecia,16126239,2
5,22.0,Emotional distress,16126239,6
0,22.0,Alopecia,16126269,2
1,22.0,Anxiety,16126269,6
2,22.0,Pain,16126269,6
3,22.0,Emotional distress,16126269,6
4,22.0,Impaired quality of life,16126269,6
5,22.0,Psychological trauma,16126269,6
0,22.0,Impaired quality of life,16126270,6
1,22.0,Psychological trauma,16126270,6
2,22.0,Pain,16126270,6
3,22.0,Alopecia,16126270,2
4,22.0,Anxiety,16126270,6
5,22.0,Emotional distress,16126270,6
0,21.1,Off label use,16126273,6
0,22.0,Stress fracture,16126274,6
0,21.1,Palmar-plantar erythrodysaesthesia syndrome,16126315,6
1,21.1,Mucosal toxicity,16126315,6
2,21.1,Diarrhoea,16126315,6
0,21.1,Vena cava thrombosis,16126321,6
1,21.1,Embolism venous,16126321,3
0,21.1,Dyspnoea,16126332,1
0,21.1,Agranulocytosis,16126344,1
0,21.1,Agranulocytosis,16126345,1
1,21.1,Leukopenia,16126345,1
0,21.1,Agranulocytosis,16126347,1
0,21.1,Leukopenia,16126348,1
1,21.1,Agranulocytosis,16126348,1
0,22.1,Fatigue,16126420,1
1,22.1,Nephritis,16126420,3
0,22.0,Drug ineffective,16126436,6
0,21.1,Death,16126450,5
1,21.1,Off label use,16126450,6
2,21.1,Intentional product use issue,16126450,6
0,21.1,Disease progression,16126468,5
0,21.1,Disease progression,16126474,5
0,22.1,Acute myeloid leukaemia,16126480,5
0,21.1,Hepatitis acute,16126506,2
0,22.0,Intra-abdominal fluid collection,16126507,
1,22.0,Fatigue,16126507,
0,21.1,Intentional product use issue,16126510,6
1,21.1,Disease progression,16126510,5
2,21.1,Off label use,16126510,6
0,21.1,Ischaemic stroke,16126512,4
0,21.1,Atrial fibrillation,16126521,1
1,21.1,Dyspnoea,16126521,1
0,21.1,Metastases to central nervous system,16126530,1
1,21.1,Central nervous system necrosis,16126530,3
2,21.1,Drug ineffective,16126530,6
0,21.1,Decreased appetite,16126557,3
1,21.1,Gingival bleeding,16126557,3
2,21.1,Faeces discoloured,16126557,6
3,21.1,Stomatitis,16126557,6
4,21.1,Back pain,16126557,3
5,21.1,Abdominal pain upper,16126557,6
6,21.1,Face oedema,16126557,6
7,21.1,Arthralgia,16126557,3
0,21.1,Haematochezia,16126632,2
0,22.0,Vomiting,16126657,5
1,22.0,Enterocolitis,16126657,5
2,22.0,Large intestine perforation,16126657,5
3,22.0,Stomatitis,16126657,3
4,22.0,Diarrhoea,16126657,5
5,22.0,Campylobacter infection,16126657,6
0,22.0,Thrombocytopenia,16126699,
0,22.0,Disease progression,16126701,
0,22.0,Immune thrombocytopenic purpura,16126709,5
1,22.0,Colitis,16126709,1
0,21.1,Dermatitis acneiform,16126725,1
0,22.0,Therapy non-responder,16126726,1
1,22.0,Disease progression,16126726,1
0,22.0,Acute kidney injury,16126770,1
1,22.0,Blood glucose decreased,16126770,6
2,22.0,Platelet count decreased,16126770,6
3,22.0,C-reactive protein increased,16126770,6
4,22.0,Eosinophil count increased,16126770,6
5,22.0,Urinary tract infection,16126770,1
6,22.0,Lymphocyte count decreased,16126770,6
7,22.0,Neutrophil count increased,16126770,6
8,22.0,Monocyte count increased,16126770,6
9,22.0,Blood sodium increased,16126770,6
10,22.0,Basophil count increased,16126770,6
11,22.0,Blood lactate dehydrogenase increased,16126770,6
0,22.0,Paraesthesia,16126780,1
1,22.0,Angina pectoris,16126780,1
2,22.0,Epistaxis,16126780,6
0,21.1,Periodontal disease,16126788,6
1,21.1,Osteonecrosis of jaw,16126788,6
0,21.1,Left ventricular dysfunction,16126793,4
0,22.0,Laryngospasm,16126807,1
1,22.0,Diarrhoea,16126807,1
2,22.0,Paraesthesia,16126807,1
3,22.0,Dyspnoea,16126807,1
0,21.1,Fall,16126808,6
1,21.1,Gait deviation,16126808,3
2,21.1,Muscular weakness,16126808,3
0,21.1,Hyperthyroidism,16126809,1
0,22.0,Sense of oppression,16126815,1
1,22.0,Erythema,16126815,1
2,22.0,Cough,16126815,1
3,22.0,Hypersensitivity,16126815,1
0,21.1,Paraesthesia,16126851,2
1,21.1,Nausea,16126851,2
2,21.1,Abdominal pain upper,16126851,2
0,21.1,Anaphylactic shock,16126853,2
1,21.1,Bronchospasm,16126853,2
2,21.1,Pharyngeal oedema,16126853,2
0,21.1,Diarrhoea,16126866,6
1,21.1,Haematotoxicity,16126866,6
2,21.1,Stomatitis,16126866,6
0,21.1,Cardiac arrest,16126903,2
1,21.1,Ventricular fibrillation,16126903,2
2,21.1,Arteriospasm coronary,16126903,2
3,21.1,Myocardial infarction,16126903,2
